Navigation Links
PharmaTelevision Launches the First Daily News Show for the Life Sciences Industry
Date:8/17/2009

OXFORD, England, August 17 /PRNewswire/ -- PharmaTelevision(R), the authoritative channel for the pharmaceutical, biotechnology and related industries, announced today the launch of its new service PharmaTelevision News (PTV News), the World's first daily television news and analysis programme for the sector.

Dr Fintan Walton, CEO of PharmaVentures - the company behind PharmaTelevision - said, "By launching PTV News, we are bringing a dynamic daily programme, covering the business of healthcare. This is a significant development, especially when you need to understand the current rapid evolution and challenges faced by our industry. Company executives and those in government and academia crave up-to-the-minute and incisive analysis - in a format that is accessible and convenient to them. And that's what PTV News is all about."

Dr Walton continues, "PharmaTelevision has already established a reputation for authoritative programming because we understand what pharmaceutical and biotechnology companies' executives want. Many of our viewers are C-Suite executives, and PTV News will be invaluable to them and many others in the industry and related services."

PTV News is produced and presented by Paul Larsmon. Mr Larsmon has worked as a broadcast television journalist for 25 years, covering general news, business and politics. He has been both presenter and producer in several news broadcasters, including the major British television news company ITN. He joined PharmaTelevision as Executive Producer earlier this year and has been responsible for getting PTV News launched. Mr Larsmon said: "This has been an exciting project involving everything from commissioning a fantastic set to organising a news gathering operation. We have seen a huge amount of interest from the industry and established an excellent pool of top commentators from around the world for the programme. I'm a news man to my core, and I'm really looking forward to developing PTV News into the best of its kind in business television."

PTV News is available on free trial for a limited time to viewers subscribing to the PharmaTelevision Premium Content package. Interested parties should contact enquiries@pharmatelevision.com, or go to the website http://www.pharmatelevision.com. Dr Walton says, "PharmaTelevision already addresses the current issues and future predictions of the industry, including those of the top companies, through news, analysis, interviews, panels and discussions. Interviewees come from leading corporations such as Johnson & Johnson, Merck & Co., sanofi-aventis, GSK, MerckSerono, and Roche."

In addition to the News, subscribers to PharmaTelevision Premium Content can access over 200 high quality interviews and panel discussions recorded since June 2006, with fresh content delivered on a regular basis. Dr Walton concludes, "Content from PTV News and other programmes from PharmaTelevision Premium Content will be shortly available through other pay-to-view outlets. Digital television has come of age - and we are delivering the programming our industry needs."

About PharmaTelevision(R)

PharmaTelevision (http://www.pharmatelevision.com) is the groundbreaking online TV channel for the pharmaceutical and biotech sector, offering insight, featured interviews, panel discussions and company information. Since May 2006, PharmaTelevision has rapidly grown and the channel now boasts over 200 TV programmes with a truly global audience, 60% of whom are C-suite executives. PharmaTelevision's TV programmes include Financial Report and the Regional Report, giving our viewers a complete overview of industry trends, analysis including deals, investments and strategic policies within the sector. Now in 2009, PharmaTelevision is launching PTV News - a daily summary and analysis of the major news headlines, ensuring that, wherever in the world they are, our audience can stay truly informed.

Watch the PTV News trailer at

http://www.pharmatelevision.com/Video/274-PTV-News--Promo.aspx

Testimonials about the value of PharmaTelevision from industry leading figures can be viewed online at http://www.pharmatelevision.com/VideoHandler.aspx?ID=166&Type=flv

A promotional Video about PharmaTelevision can be viewed online at: http://www.pharmatelevision.com/VideoHandler.aspx?ID=270

PharmaTelevision is a part of the business media division of PharmaVentures Ltd (http://www.pharmaventures.com).

Notes to Editors:

About PharmaVentures

A leading results driven organisation, PharmaVentures ( http://www.pharmaventures.com) assists pharmaceutical and biotechnology companies across the world in all aspects of deal making and business intelligence. The Company provides tailored consulting and transaction advisory services to the Life Science industry, with additional deal making support provided through the PharmaDeals(R) range of intelligence products that include analysis tools and reports. An innovative business, PharmaVentures additionally provides industry insight through the world's first dedicated online pharmaceutical television channel http://www.pharmatelevision.com.

Now in its 17th year, PharmaVentures is based in Oxford, UK, employs over 50 people mostly educated to PhD or above, and has increased its turnover five fold with 80% of revenues from outside the UK. With offices in the USA and Australia, the Company works for a variety of clients from start-ups to global corporate pharmaceutical companies.

PharmaTelevision(R) and PharmaDeals(R) are registered Trade Marks of PharmaVentures Ltd.

For further information, or to receive a demonstration of the new service, please contact:

    For further information about PharmaVentures, please contact:
    Lisa Holloway, Marketing
    +44(0)1865-784-177
    lisa.holloway@pharmaventures.com


'/>"/>
SOURCE PharmaVentures
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Research Triangle Area Health Care Collaborative Launches Bridges to Excellence(R) Initiative to Improve Quality and Lower Costs
2. Novozymes Launches Enzyme to Reduce Acrylamide in Food
3. Enova Medical Launches Exos Corporation
4. Elekta Launches New Linear Accelerator at 2007 ESTRO to Expand Cancer Treatment Availability
5. Signalifes Dr. Harmison Launches Award-Winning Ambulatory Heart Monitor
6. ThirdBiotech Networking Group Launches
7. BioReliance Launches Next-Generation Genotoxicity Screening Service
8. Midwest Research Institute Launches Center for Biological Safety and Security (CBS2)
9. BioReliance Corporation Launches iNet(TM) for Online Results Tracking of Biological Safety Tests
10. Kingfisher Healthcare Launches Breakthrough Product in Europe
11. Spectral partner launches EAA(TM) Rapid Sepsis Diagnostic in Germany
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... and LAGUNA HILLS, Calif. , Oct. ... Cancer Research, London (ICR) and University ... SKY92, SkylineDx,s prognostic tool to risk-stratify patients with multiple myeloma ... MUK nine . The University of Leeds ... partly funded by Myeloma UK, and ICR will perform the ...
(Date:10/10/2017)... ... 2017 , ... San Diego-based team building and cooking events company, Lajollacooks4u, has ... The bold new look is part of a transformation to increase awareness, appeal to ... period. , It will also expand its service offering from its signature gourmet cooking ...
(Date:10/10/2017)... 10, 2017 International research firm Parks Associates announced ... at the TMA 2017 Annual Meeting , October 11 in ... residential home security market and how smart safety and security products impact ... Parks Associates: Smart Home ... "The residential security market has ...
(Date:10/9/2017)... DIEGO , Oct. 9, 2017  BioTech ... biological mechanism by which its ProCell stem cell ... critical limb ischemia.  The Company, demonstrated that treatment ... amount of limbs saved as compared to standard ... the molecule HGF resulted in reduction of therapeutic ...
Breaking Biology Technology:
(Date:3/28/2017)... , March 28, 2017 The ... Hardware (Camera, Monitors, Servers, Storage Devices), Software (Video Analytics, ... Region - Global Forecast to 2022", published by MarketsandMarkets, ... 2016 and is projected to reach USD 75.64 Billion ... and 2022. The base year considered for the study ...
(Date:3/24/2017)... 24, 2017 The Controller General of Immigration from ... Abdulla Algeen have received the prestigious international IAIR Award for the ... Continue Reading ... ... Controller Abdulla Algeen (small picture on the right) have received the IAIR ...
(Date:3/23/2017)... The report "Gesture Recognition and Touchless Sensing Market by Technology (Touch-based ... to 2022", published by MarketsandMarkets, the market is expected to be worth USD ... 2022. Continue Reading ... ... ...
Breaking Biology News(10 mins):